Beware renal adverse effects of anti-vascular endothelial growth factor treatment

被引：4
作者：
Keir, Lindsay [1 ]
van Moorsel, Feike [2 ]
Saleem, Moin A. [3 ]
Richards, Anna [4 ]
机构：
[1] Univ Bristol, Southmead Hosp, Acad Renal Unit, Bristol, Avon, England
[2] Univ Utrecht, Utrecht, Netherlands
[3] Bristol Royal Hosp Children, Childrens Renal Unit, Bristol, Avon, England
[4] Univ Edinburgh, MRC, Ctr Inflammat Res, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2012年 / 344卷
基金：
英国医学研究理事会;
关键词：
BEVACIZUMAB;
D O I：
10.1136/bmj.e3838
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
[31]   Vascular endothelial growth factor gene polymorphism prevalence in patients with diabetic macular oedema and its correlation with anti-vascular endothelial growth factor treatment outcomes [J].
El-Shazly, Sherien F. ;
El-Bradey, Mohamed H. ;
Tameesh, Mohamed K. .
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 42 (04) :369-378
[32]   Anti-VEGF (anti-vascular endothelial growth factor)-treatment for central vein occlusion during breastfeeding [J].
Groselli, S. ;
Bechstein, L. ;
Gabka, K. ;
Ulbig, M. .
OPHTHALMOLOGIE, 2023, 120 (07) :751-754
[33]   Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema [J].
Jampol, Lee M. ;
Glassman, Adam R. ;
Liu, Danni ;
Aiello, Lloyd Paul ;
Bressler, Neil M. ;
Duh, Elia J. ;
Quaggin, Susan ;
Wells, John A. ;
Wykoff, Charles C. .
OPHTHALMOLOGY, 2018, 125 (07) :1054-1063
[34]   Current Anti-Vascular Endothelial Growth Factor Dosing Regimens Benefits and Burden [J].
Haller, Julia A. .
OPHTHALMOLOGY, 2013, 120 (05) :S3-S7
[35]   Ocular Hypertension Following Intravitreal Anti-vascular Endothelial Growth Factor Agents [J].
Ravi S. J. Singh ;
Judy E. Kim .
Drugs & Aging, 2012, 29 :949-956
[36]   ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NAIVE IDIOPATHIC CHOROIDAL NEOVASCULARIZATION [J].
Sudhalkar, Aditya ;
Yogi, Rohit ;
Chhablani, Jay .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (07) :1368-1374
[37]   Systemic Safety of Bilateral Intravitreal Anti-Vascular Endothelial Growth Factor Injections [J].
Freund, K. Bailey ;
Vance, Sushma K. .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011, 31 (01) :1-3
[38]   INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR RETINOPATHY OF PREMATURITY Comparison Between Ranibizumab and Bevacizumab [J].
Chen, San-Ni ;
Lian, Iebin ;
Hwang, Ya-Chi ;
Chen, Yi-Hsing ;
Chang, Yao-Chung ;
Lee, Kun-Hsien ;
Chuang, Chih-Chun ;
Wu, Wei-Chi .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (04) :667-674
[39]   Anti-vascular endothelial growth factor treatment for retinal conditions: a systematic review and meta-analysis [J].
Pham, Ba' ;
Thomas, Sonia M. ;
Lillie, Erin ;
Lee, Taehoon ;
Hamid, Jemila ;
Richter, Trevor ;
Janoudi, Ghayath ;
Agarwal, Arnav ;
Sharpe, Jane P. ;
Scott, Alistair ;
Warren, Rachel ;
Brahmbhatt, Ronak ;
Macdonald, Erin ;
Straus, Sharon E. ;
Tricco, Andrea C. .
BMJ OPEN, 2019, 9 (05)
[40]   "Attenuated" Pulmonary Tumor Thrombotic Microangiopathy on Anti-Vascular Endothelial Growth Factor Treatment: A Case Report [J].
Ozaki, Haruka ;
Yamaguchi, Takeshi ;
Kizawa, Rika ;
Tanabe, Yuko ;
Suyama, Koichi ;
Miura, Yuji .
CASE REPORTS IN ONCOLOGY, 2025, 18 (01) :659-666
12345